|Page (1) of 1 - 05/21/12||email article||print page|
Cytotoxic Therapies Market Estimated to Decline Marginally by 2017(May 21, 2012)
ROCKVILLE, MD -- (Marketwire) -- 05/21/12 -- MarketResearch.com has announced the addition of the new report "Cytotoxic Therapies Market to 2017 - Launch of Next Generation Camptothecin Analogues Will Help Offset Revenue Loss due to Generic Erosion," to their collection of Generics Drugs market reports. For more information, visit http://www.marketresearch.com/GBI-Research-v3759/Cytotoxic-Therapies-Launch-Generation-Camptothecin-6927058/
In 2010, the cytotoxic therapies market for eight major oncology indications was estimated at $10.1 billion, indicating a compound annual growth rate (CAGR) of 5.8% since 2002. GBI Research forecasts the market to decline marginally at a CAGR of (0.1%) between 2010 and 2017, to record a sales value of $10.1 billion by 2017. The eight indications covered are breast cancer, cervical cancer, colorectal cancer, head and neck cancer, non-Hodgkin lymphoma, non-small cell lung cancer, ovarian cancer, and prostate cancer. The growth in major markets such as the US, the top five countries of Europe, and Japan, was driven mainly by the increasing prevalence and prescription population, and the combination of cytotoxic medicines with biologics, while the overall decline in market value is a result of patent expiries in the forecast period and subsequent reduction in annual cost of therapy.
The US was the leading geography, with an estimated sales value of $5.5 billion and an approximate share of 55%. The US market is expected to decline at a rate of (1.7%) between 2010 and 2017, to record a sales value of $4.9 billion in 2017. The top five countries of Europe together contributed to sales worth $3.3 billion in 2010, accounting for an approximate global share of 32.4%. The top five countries of Europe are expected to record sales worth $3.8 billion by the year 2017, registering a growth rate of 2%. Japan, in 2010, contributed $1.3 billion to the global market, increasing at a CAGR of 4.5% from 2002. It accounts for an approximate share of 12.6%. Decreasing at a rate of (1.1%) between 2010 and 2017, the market is expected to record sales worth $1.2 billion by 2017.
For more information, visit http://www.marketresearch.com/GBI-Research-v3759/Cytotoxic-Therapies-Launch-Generation-Camptothecin-6927058/
MarketResearch.com is the leading provider of global market intelligence products and services. With research reports from more than 720 top consulting and advisory firms, MarketResearch.com offers instant online access to the world's most extensive database of expert insights on global industries, companies, products, and trends. Moreover, MarketResearch.com's Research Specialists have in-depth knowledge of the publishers and the various types of reports in their respective industries and are ready to provide research assistance. For more information, call Veronica Franco at 240-747-3016 or visit http://www.marketresearch.com.
Copyright @ Marketwire
Related Keywords: MarketResearch.com, Japan,Marketwire, ,Medical,Cancer,